Johnson & Johnson Innovation - JJDC Form 4/A Change in insider ownership (amended)

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Johnson & Johnson Innovation - JJDC, Inc.

(Last)

(First)

(Middle)

410 GEORGE STREET

(Street)

NEW BRUNSWICK

08901

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)
09/18/2023

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$0.237	09/15/2023		J⁽¹⁾⁽²⁾			237	⁽³⁾	12/14/2023	Common Stock	237	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$0.237	09/15/2023		J⁽¹⁾⁽²⁾			158	⁽³⁾	11/18/2024	Common Stock	158	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$0.237	09/15/2023		J⁽¹⁾⁽²⁾			189	⁽³⁾	08/06/2025	Common Stock	189	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$0.237	09/15/2023		J⁽¹⁾⁽²⁾			165	⁽³⁾	08/06/2025	Common Stock	165	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$0.237	09/15/2023		J⁽¹⁾⁽²⁾			118	⁽³⁾	08/06/2025	Common Stock	118	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$0.237	09/15/2023		J⁽¹⁾⁽²⁾			71	⁽³⁾	08/06/2025	Common Stock	71	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$0.237	09/15/2023		J⁽¹⁾⁽²⁾			23	⁽³⁾	08/06/2025	Common Stock	23	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$0.237	09/15/2023		J⁽¹⁾⁽²⁾			85	⁽³⁾	11/09/2025	Common Stock	85	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$0.237	09/15/2023		J⁽¹⁾⁽²⁾			758	⁽³⁾	02/01/2027	Common Stock	758	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$0.237	09/15/2023		J⁽¹⁾⁽²⁾			489	⁽³⁾	02/01/2027	Common Stock	489	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$0.237	09/15/2023		J⁽¹⁾⁽²⁾			758	⁽³⁾	02/15/2028	Common Stock	758	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$0.237	09/15/2023		J⁽¹⁾⁽²⁾			300	⁽³⁾	02/15/2028	Common Stock	300	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$1.186	09/15/2023		J⁽¹⁾⁽²⁾			758	⁽³⁾	11/28/2028	Common Stock	758	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$1.186	09/15/2023		J⁽¹⁾⁽²⁾			142	⁽³⁾	11/28/2028	Common Stock	142	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$3.955	09/15/2023		J⁽¹⁾⁽²⁾			758	⁽⁴⁾	12/05/2029	Common Stock	758	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾
Stock Option (Right to Buy)⁽¹⁾⁽²⁾	$5.141	09/15/2023		J⁽¹⁾⁽²⁾			1,264	⁽⁵⁾	01/04/2031	Common Stock	1,264	⁽¹⁾⁽²⁾	0	D⁽¹⁾⁽²⁾

Explanation of Responses:

1. This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law,

2. (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein.

3. Fully vested.

4. Vests as to 1/48th of the shares each month commencing January 6, 2020.

5. Vests as to 1/48th of the shares each month commencing January 11, 2021.

	Johnson & Johnson Innovation - JJDC, Inc., By: /s/ Jill McManus, Assistant Treasurer	02/02/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Johnson & Johnson Innovation - JJDC Form 4/AChange in insider ownership (amended)